G. R. Pape

3.3k total citations · 1 hit paper
36 papers, 2.6k citations indexed

About

G. R. Pape is a scholar working on Hepatology, Immunology and Epidemiology. According to data from OpenAlex, G. R. Pape has authored 36 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hepatology, 18 papers in Immunology and 16 papers in Epidemiology. Recurrent topics in G. R. Pape's work include Hepatitis C virus research (22 papers), Hepatitis B Virus Studies (14 papers) and Immune Cell Function and Interaction (9 papers). G. R. Pape is often cited by papers focused on Hepatitis C virus research (22 papers), Hepatitis B Virus Studies (14 papers) and Immune Cell Function and Interaction (9 papers). G. R. Pape collaborates with scholars based in Germany, Sweden and United States. G. R. Pape's co-authors include Helmut M. Diepolder, Robert M. Hoffmann, Roman Zachoval, M. Jung, Teresa Santantonio, E A Wierenga, G. Riethmüller, D. Eichenlaub, Ulrich Spengler and MC Jung and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

G. R. Pape

35 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1995 586 citations Helmut M. Diepolder, Roman Zachoval et al. The Lancet profile →

Peers

G. R. Pape

HEPAT

EPIDE

IMMUN

RNMI

Robert M. Hoffmann United States

Winfried Schraut Germany

Hans Christian Spangenberg Germany

Norbert H. Gruener Germany

Tilman Gerlach Germany

Fritz von Weizsäcker Germany

Maria–Christina Jung Germany

H Löhr Germany

Tomasz I. Michalak Canada

F Fiaccadori Italy

Robert M. Hoffmann United States

G. R. Pape

3.2k ×2.1

HEPAT

2.2k ×1.7

EPIDE

1.0k ×0.9

IMMUN

290 ×0.9

RNMI

262 ×1.0

Citations per year, relative to G. R. Pape G. R. Pape (= 1×) peers Robert M. Hoffmann

Countries citing papers authored by G. R. Pape

Since Specialization

Citations

This map shows the geographic impact of G. R. Pape's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. R. Pape with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. R. Pape more than expected).

Fields of papers citing papers by G. R. Pape

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. R. Pape. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. R. Pape. The network helps show where G. R. Pape may publish in the future.

Co-authorship network of co-authors of G. R. Pape

This figure shows the co-authorship network connecting the top 25 collaborators of G. R. Pape. A scholar is included among the top collaborators of G. R. Pape based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. R. Pape. G. R. Pape is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ulsenheimer, Axel, Michaela Lucas, Nilufer P. Seth, et al.. (2006). Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T‐cell responses. Journal of Viral Hepatitis. 13(10). 708–714. 25 indexed citations

Berg, Thomas, V Weich, G Teuber, et al.. (2006). 559 Individualized treatment strategy with peginterferon alpha-2b (PEG-IFN a) plus ribavirin according to early viral kinetics in hepatitis C virus (HCV) type 1 infected patients. Journal of Hepatology. 44. S208–S208. 4 indexed citations

Gerlach, J. Tilman, Helmut M. Diepolder, G. R. Pape, & Axel Ulsenheimer. (2004). Reply. Gastroenterology. 126(4). 1220–1220. 1 indexed citations

Berg, Thomas, Holger Hinrichsen, Tobias Heintges, et al.. (2003). 328 Comparison of 48 or 72 weeks of treatment with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment-naive patients with chronic hepatitis C infected with HCV genotype 1. Hepatology. 38. 317–317. 11 indexed citations

Pape, G. R.. (2001). Analyse der Immunantwort bei Hepatitis C. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 44(6). 593–597.

Schirren, C, M.C. Jung, Thomas Worzfeld, et al.. (2000). Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection. Liver Transplantation. 6(2). 222–228. 29 indexed citations

Pape, G. R., et al.. (1999). Role of the specific T‐cell response for clearance and control of hepatitis C virus. Journal of Viral Hepatitis. 6(s1). 36–40. 91 indexed citations

Hoffmann, Robert M., Thomas Berg, G Teuber, et al.. (1999). Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis C.. PubMed. 37(8). 715–23. 13 indexed citations

Diepolder, Helmut M., Robert M. Hoffmann, J. Tilman Gerlach, et al.. (1998). Immunopathogenesis of HCV Infection. PubMed. 135–151. 7 indexed citations

10.

Diepolder, Helmut M., E. Keller, W. Schraut, et al.. (1998). A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clinical & Experimental Immunology. 113(2). 244–251. 71 indexed citations

11.

Riethmüller, G., et al.. (1997). Analysis of T cell activation pathways in patients with liver cirrhosis, impaired delayed hypersensitivity and other T cell-dependent functions. Clinical & Experimental Immunology. 108(1). 144–150. 36 indexed citations

12.

Diepolder, Helmut M., Roman Zachoval, Robert M. Hoffmann, et al.. (1996). The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C. Journal of Molecular Medicine. 74(10). 583–588. 87 indexed citations

13.

Diepolder, Helmut M., M.C. Jung, E A Wierenga, et al.. (1996). Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro. Journal of Virology. 70(11). 7540–7548. 32 indexed citations

14.

Diepolder, Helmut M., Roman Zachoval, Robert M. Hoffmann, et al.. (1995). Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. The Lancet. 346(8981). 1006–1007. 586 indexed citations breakdown →

15.

Jung, M., Helmut M. Diepolder, & G. R. Pape. (1994). T cell recognition of hepatitis B and C viral antigens. European Journal of Clinical Investigation. 24(10). 641–650. 35 indexed citations

16.

Santantonio, Teresa, Maria–Christina Jung, Laura Monno, et al.. (1993). Long-term response to interferon therapy in chronic hepatitis B: importance of hepatitis B virus heterogeneity. PubMed. 8. 171–178. 3 indexed citations

17.

Messer, Gerald, Ulrich Spengler, M. Jung, et al.. (1991). Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production.. The Journal of Experimental Medicine. 173(1). 209–219. 475 indexed citations

18.

Santantonio, Teresa, M. Jung, Ralf Schneider, et al.. (1991). Identification of HBV pre-S mutants and their intrafamilial spreading. Journal of Hepatology. 13. S69–S69. 1 indexed citations

19.

Weimer, Thomas, et al.. (1989). Immunogenicity of human hepatitis B virus P-gene derived proteins.. The Journal of Immunology. 143(11). 3750–3756. 17 indexed citations

20.

Pape, G. R., �. Larsson, Staffan Paulie, et al.. (1980). Disease-related lymphocyte cytotoxicity in vitro in patients with transitional cell carcinoma of the urinary bladder. Comparisons with other malignancies, acute cystitis, and healthy donors. Cancer Immunology Immunotherapy. 8(1). 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact